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Summary
Signal-transduction networks can display complex dynamic
behavior such as oscillations in the activity of key compo-
nents [1–6], but it is often unclear whether such dynamic
complexity is actually important for the network’s regulatory
functions [7, 8]. Here, we found that the mitogen-activated
protein kinase (MAPK) Fus3, a key regulator of the yeast
mating-pheromone response, undergoes sustained oscilla-
tions in its phosphorylation and activation state during
continuous pheromone exposure. These MAPK activity os-
cillations led to corresponding oscillations in mating-gene
expression. Oscillations in MAPK activity and gene expres-
sion required the negative regulator of G protein signaling
Sst2 and partially required the MAPK phosphatase Msg5.
Peaks in Fus3 activation correlated with periodic rounds of
cell morphogenesis, with each peak preceding the formation
of an additional mating projection. Preventing projection
formation did not eliminate MAPK oscillation, but preventing
MAPK oscillation blocked the formation of additional projec-
tions. Amathematical model was developed that reproduced
several features of the observed oscillatory dynamics. These
observations demonstrate a role for MAPK activity oscilla-
tion in driving a periodic downstream response and explain
how the pheromone signaling pathway, previously thought
to desensitize after 1–3 hr, controls morphology changes
that continue for a much longer time.
Results and Discussion
The Yeast Mating Pathway Is Initially Transiently Activated
In haploid yeast cells, MAPK signaling is activated in response
to pheromone secreted by a cell of the opposite mating type.
As a consequence, the yeast arrest their cell cycle in the G1
phase and initiate a developmental program characterized
by alterations in gene expression, oriented growth toward
the mating partner (mating-projection formation), and, ulti-
mately, fusion of the two haploid cells to form a diploid [9, 10].
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coupled receptor triggers a signal-transduction cascade
containing the MAPKs Fus3 and Kss1. These MAPKs share
more than 50% sequence identity with human ERK1 and
ERK2, and like ERK1/2 are activated via dual phosphorylation
by a MAPK kinase (yeast Ste7) and deactivated by various
MAPK phosphatases.
Previous studies of the pheromone response have indicated
that it is relatively short lived, with MAPK activity and phero-
mone-induced transcript levels peaking within the first hour
of stimulation and returning to their unstimulated baseline
levels 2–4 hr after pheromone addition [11–13]. This apparent
desensitization is a hallmark of G protein-coupled receptor
pathways [9].
MAPK Activation Levels Oscillate
Because the physiological response to pheromone can persist
for many hours under certain circumstances [14–16], we won-
dered how physiological responses persisted if the pathway
was stably desensitized. To gain some preliminary insight
into this question, we performed an extended time course in
asynchronous, mid-log cultures. Surprisingly, after approxi-
mately 3–5 hr of continuous pheromone exposure, MAPK
activation returned to near-peak levels (Figure S1 available
online).
To investigate MAPK oscillations at a higher level of resolu-
tion, we synchronized cells carrying an integrated fusion of
Fus3MAPK to enhanced green fluorescent protein (GFP) by S
phase arrest and release, and we added pheromone to cells
during the G1 phase, when the mating response is maximal
(three different pheromone doses were tested). The treated
cells were then monitored for MAPK phosphorylation levels,
Fus3-GFP fluorescence and localization, and cell morphology
(Figure 1A). The set of strains used for these experiments
lacked the Bar1 protease, which allowed us to remove the
potentially confusing effects of pheromone proteolysis (in
contrast, the strain used for Figure S1 was BAR1+). As shown
in Figure 1B, in these G1-synchronized cells, an initial peak of
MAPK activation occurred within 60 min of pheromone addi-
tion and then declined, consistent with the short time-course
studies cited above. When observed over an 8 hr time course,
however, sustained oscillations of MAPK activity were pres-
ent: Phospho-Fus3 levels rose again, fell again, and then
rose and fell yet a third time. Elevated activation of Fus3
occurred at approximately 60, 180–240, and 420–480 min after
stimulation (Figure 1C), with activation of Kss1MAPK roughly
paralleling this trend (Figure 1B). As assessed by microscopic
examination, cells remained in G1 arrest during the entire 8 hr
time course (data not shown); thus, re-entry into the cell cycle
did not account for the observed oscillation. In summary,
MAPK activation levels oscillate, with three distinct peaks
over 8 hr of persistent stimulation.
The Expression of MAPK Target Genes Oscillates
During mating, activated Fus3MAPK and Kss1MAPK phosphory-
late the transcriptional regulators Ste12, Dig1, and Dig2 [10],
resulting in the upregulation and downregulation of multiple
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cell fusion (such as FUS1), genes encoding negative regulators
of the pathway (such asSST2 andMSG5), and genes encoding
certain members of the signaling pathway itself (such as FUS3)
[17]. To determine whether the oscillations in MAPK activation
resulted in corresponding oscillations of pheromone-induced
gene transcription, we monitored the expression levels of both
Fus3-GFP and Fus1-GFP by immunoblotting (Figures 1D and
1E) and flow cytometry (data not shown). Both methods
showed that Fus3-GFP and Fus1-GFP protein levels displayed
strong oscillatory dynamics with frequencies similar to the os-
cillations of Fus3 activation. Furthermore, increasing the pher-
omone dose resulted in a progressive phase shift of Fus3-GFP
expression peaks toward earlier time points (Figure 1D); this
trend was also observed for phospho-MAPK levels (Figure 1C),
although it was less apparent. In general, the peaks in protein
expression levels roughly coincided with the peaks in phos-
pho-Fus3, as expected given the relatively slow oscillatory
period of the latter (a notable exception, however, was the
oscillation in Sst2 protein levels; see below). In summary, the
expression levels of MAPK target genes oscillate in approxi-
mate synchrony with MAPK activation levels.
Oscillation Requires the Negative Regulators Sst2
and Msg5: Model and Experiment
Oscillatory behavior is often a sign of the presence of at least
one negative feedback mechanism in the underlying molecular
interactions, although negative feedback does not necessarily
entail oscillation [18], and oscillation does not strictly require
a classical negative feedback loop [19]. Several negative
regulators have been shown to affect the mating pathway,
including the MAPK phosphatase Msg5 and the regulator of
G protein signaling (RGS) protein Sst2 [20, 21]. Msg5 dephos-
phorylates and thereby deactivates Fus3, but its function is
partially redundant with those of several other phosphatases
[11]. Thus, cells lacking Msg5 display a modest increase in
pheromone sensitivity. Sst2 binds to the pheromone receptor
and stimulates the GTPase activity of the pheromone-recep-
tor-coupled G protein; cells lacking Sst2 display severe hyper-
sensitivity to pheromone [21]. Given that bothMSG5 and SST2
are pheromone-inducible genes, they are components of neg-
ative feedback loops that might control the oscillatory activity
of the pathway [20, 22].
To gain theoretical insight regarding how negative feedback
might modulate the properties of the pheromone signaling
network, we developed a mathematical model of a MAPK sig-
naling cascade with negative feedback, and we parameterized
the model with values appropriate to the yeast pheromone-
response pathway (see Supplemental Data). Model simula-
tions (Figure 2A) testing the role of different pheromone doses
on Fus3MAPK activation rates reproduced the observed depen-
dence of oscillation amplitude on dose strength. In addition,
this analysis predicted a slight phase shift with dose variation
and increased dampening of the oscillations with decreasing
dose (see a more extensive model analysis in the Supplemen-
tal Data); both these trends were apparent in the experimental
data. Further, the model predicted that Sst2 expression would
oscillate with the same frequency as did Fus3 phosphorylation
and activation levels, but it should be shifted in phase (Fig-
ure 2B); this prediction was supported by examination of a
wild-type strain stimulated with 100 nM a-factor (Figure 2C).
Not surprisingly, the model also predicted that decreasing
the strength of the negative feedback (by removing Sst2 or
lowering its activity) would dampen MAPK activity oscillations(Figure 2D). These theoretical results show that Sst2-mediated
negative feedback is, in principle, sufficient for generating
oscillations resembling those observed experimentally.
To experimentally investigate the role of Sst2 and Msg5 on
MAPK oscillation, we compared a wild-type strain to an other-
wise isogenic strain lacking Sst2 (i.e., an sst2D strain). In the
strain lacking Sst2, Fus3 activation persisted for at least 8 hr
after pheromone addition, without obvious oscillations (Fig-
ure 2E). In addition, in anmsg5D strain, the oscillation of active
Fus3 was present but substantially damped (Figure 2F). Oscil-
lations in the expression of pheromone-induced genes (as
represented by Fus3-GFP) were also compromised in sst2D
and msg5D strains (Figures 2E and 2F; plotted in Figures 3C
and 3D). In summary, the negative regulators Sst2 and Msg5
are required for wild-type oscillatory dynamics. Further work
is needed to address whether negative feedback per se is
also required.
Frequency of Oscillations in Gene Expression
and Projection Formation Are Correlated
Mating-projection formation may occur either by polarization
in the strongest pheromone gradient emanating from an adja-
cent mating partner [14, 16] or, when gradients are too shallow
or variable to be detected precisely, by sequential formation
of multiple projections in random directions (the ‘‘default
response’’) [15, 23]. Cells can also form a second projection
when the direction of the gradient is switched (our unpublished
data). Multiple projections may facilitate mating in environ-
ments where cells are present in dense groups, and saturating
pheromone concentrations (or noisy, fluctuating gradients)
may arise naturally because of rapid proliferation, flocculation,
or biofilm formation.
We hypothesized that oscillations in Fus3 activation might
control the timing of the formation of multiple mating projec-
tions and that the frequency of MAPK oscillation would there-
fore correlate with the periodicity of projection formation. To
test this prediction, we quantified projection formation by
microscopic examination of the same cells that were used
for determination of the dynamics of MAPK activation and
gene expression.
As shown in Figure 3, during 8 hr of pheromone exposure,
wild-type cells exhibited a progressive increase in the number
of projections, with more than half of the cells displaying three
projections by the end of the time course (Figures 3A, 3E, and
3F); these results are similar to those previously reported [15].
Importantly, the dynamics of the onset of successive projec-
tions displayed an excellent correlation with the cycling of
both Fus3-GFP and Fus1-GFP protein levels (Figure 3A). In
particular, in cells exposed to 100 nM pheromone, the forma-
tion of the second projection coincided with the rise in gene
expression at 3–5 hr, and the formation of the third projection
coincided with the rise in gene expression at 7–8 hr. The corre-
lation between the timing of each peak in gene expression and
the formation of a new projection was preserved at the higher
pheromone dose of 25 mM, with both periodic processes un-
dergoing a noticeable phase shift toward earlier time (Fig-
ure 3B).
A second prediction arising from the hypothesis that the
MAPK oscillator drives periodic projection formation is that
genetic alterations that alter the dynamics of phospho-Fus3
oscillation should also affect the periodicity of projection
formation. To test this prediction, we evaluated projection for-
mation in sst2D and msg5D strains, in which oscillations are
severely damped. Both mutant strains formed an initial
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(A) Experimental strategy used to monitor MAPK oscillation. Cells containing an integrated Fus3-GFP fusion protein were grown to mid-log phase, then
synchronized by S phase arrest and release. When they entered the G1 phase, they were stimulated with various doses of a-factor mating pheromone
for 8 hr. Samples were collected at multiple time points and assessed by immunoblotting (for measurement of MAPK phosphorylation and protein
abundance), microscopic examination (for measurement of projection formation), and other methods.
(B) Representative immunoblots of wild-type (ZH524) cells treated with either 50 nM, 100 nM, or 25 mM a-factor for the indicated times. After separation
by SDS-PAGE in 4%–20% gradient polyacrylamide gels, phospho-Fus3-GFP and phospho-Kss1 species were detected on the immunoblots with
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probed with a GFP antibody for detection of the total levels of Fus3-GFP. As loading control, blots were probed with anti-b-tubulin.
(C) Quantification of Fus3 activation by scanning densitometry (ImageJ) of immunoreactive bands (phospho-p42/44 antibody) on autoradiographs. The Fus3
signal was normalized to b-tubulin and expressed as a percentage of the highest response for each pheromone concentration. Subsequently, the responses
were scaled by comparing the signal intensities of the three responses for the same time points in the same autoradiography film. In this and following
images, the data points were spline fitted, and each value is the average from three experiments (6SE).
(D) Quantification of Fus3-GFP protein levels (GFP antibody).
(E) Comparison of Fus3-GFP (dotted line) and Fus1-GFP (solid line) protein levels in synchronized wild-type cells (ZH424 and ZH550, respectively) treated
with 100 nM pheromone. The Fus1-GFP immunoblot is shown to the right. The multiple bands are caused by glycosylated isoforms [26]. For capturing the
pheromone-induced shift from the fastest to the slower migrating forms, the sum of all immunoreactive bands except the fastest migrating (i.e., lowest)
Fus1-GFP band was quantified. The graph is an average of the experiment shown and two additional experiments.
Figure 2. Oscillation Requires the Negative Regulators Sst2 and Msg5
(A) Analysis by mathematical modeling; see Supplemental Data for a detailed model description and analysis. Simulated Fus3 activation response to
pheromone progressively varied from 3 nM (lowest curve, dark blue) to 6 nM (blue), 10 nM (cyan), 100 nM (green), 1mM (yellow), and 10 mM (red).
(B) Modeling analysis of pathway activation, with the concentration of active Fus3 (black line) overlaid with the concentration of Sst2 (red dashed line). Both
curves are normalized so that their respective maxima are equal to unity. The phase shifting of Sst2 oscillations results from the interplay of pheromone-
induced transcription of SST2 [17] and pheromone-regulated degradation of Sst2 [22].
(C) Experimental analysis of Sst2 expression. Protein extracts were made from synchronized wild-type cells (ZH524) treated with 100 nM a-factor for the
indicated times and probed with an Sst2 antibody. The exposure level of this blot was chosen to maximize the dynamic range. The quantified data are shown
in comparison with the time course of active Fus3 levels.
(D) Modeling of the effect of Sst2 on Fus3 activation. Simulated nuclear dually phosphorylated Fus3 is plotted for different levels of Sst2 expression, with the
strength decreasing from the wild-type levels (blue) through intermediate levels (green) to no Sst2 (red).
(E and F) Experimental (immunoblot) analysis of the effect of the removal of Fus3 negative regulators sst2D (E) andmsg5D (F) on active and total Fus3 in cells
treated with 100 nM pheromone. The Fus3-GFP expression levels taken from these and replicate blots are plotted in Figures 3C and 3D.
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1704projection at a rate similar to that of the wild-type strain. Strik-
ingly, however, both mutants predominantly formed only this
single projection, even though they were continuously ex-
posed to pheromone for 8 hr (Figures 3C, 3D, and 3F).
Because the total level of active Fus3 is persistently
increased in sst2D cells after incubation with 100 nM phero-
mone, we considered the possibility that the increase in the
total amount of active Fus3, rather than the loss of the oscilla-
tion, was responsible for the defect in secondary-projection
formation. To address this question, sst2D cells were treated
with a 10-fold reduced concentration of pheromone (i.e, 10 nM).
Under these conditions, the average level of active Fus3 was
reduced to a level comparable to that of SST2+ cells treated
with 100 nM pheromone, yet the cells still only formed one
projection (data not shown); this suggests that the lack of
oscillation, rather than a change in the level of Fus3 activation,
caused the defect in periodic morphogenesis in cells lacking
Sst2. In summary, MAPK oscillations appear to drive the
periodic formation of multiple mating projections.
Projection Formation Is Not Required for MAPKOscillation
To investigate whether actin dynamics and/or projection for-
mation reciprocally regulated MAPK oscillation, we examined
Fus3 phosphorylation in a strain lacking Bni1, which is required
for the formation of actin cables and mating projections [24]. As
previously reported, in the bni1D strain, the average Fus3
Figure 3. Oscillations in Gene Expression and Projection Formation Are Correlated
Pattern of mating-projection formation in cells exposed to pheromone for the indicated times overlaid with total (dashed line) levels of target-gene
expression (Fus3-GFP).
(A and B) The effect of pheromone dose on target-gene expression and projection formation in wild-type (strain ZH524) treated with (A) 100 nM pheromone
or (B) 25 mM pheromone.
(C and D) The effect of the removal of Fus3 negative regulators (C) Sst2 (ZH525) or (D) Msg5 (ZH527) on targeted gene expression and projection formation in
cells treated with 100 nM pheromone. Each value is the average from three experiments (6SE). The percentages of cells having one (red), two (blue), three
(green), and four (magenta) projections are shown. At least 100 cells were scored per time point for each strain.
(E) Representative phase-contrast images of cell-morphology phenotypes of ethanol-fixed wild-type (ZH524) cells treated with 100 nM mating pheromone
for 0–480 min. The bar represents 10 mm.
(F) Epifluorescence imaging of Fus3-GFP (green) in cells of the indicated genotype stimulated with 100 nM pheromone for 420 min.
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in the wild-type, consistent with putative amplification of Fus3
signaling by actin cables [25]. However, the oscillatory activa-
tion and expression of Fus3-GFP was nevertheless preserved,
albeit being somewhat damped (Figures 4A–4C). Thus, the
formation of mating projections influences, but is not essential
for, MAPK oscillation.
Conclusion
Here, we demonstrated persistent oscillations in the phos-
phorylation and activation of the MAPKs Fus3 and Kss1 and
in the expression of MAPK target genes, in response to contin-
uous pheromone stimulation over an 8 hr period. In addition,
we showed that these oscillations require the negative regula-
tors SST2 andMSG5. Finally, we provided evidence linking the
oscillations in MAPK signaling to periodic changes in cell
shape and polarity that occur when cells form secondary
mating projections if the first attempt at partner location is un-
successful. Our results suggest that the yeast MAPK pathway
functions as a timer to control periodic morphogenesis, so as
to facilitate mating in shallow or noisy gradients. These
Figure 4. Projection Formation Is Not Required for MAPK Oscillation
(A) Immunoblot analysis of Fus3-GFP activation and expression in stimu-
lated (100 nM) cells lacking the formin Bni1. Note that, because of weak
signal in the bni1D strain, the time required for exposure of immunoblots
to autoradiography film was about five to six times longer than similar
time courses in the wild-type.
(B and C) Comparison of the time course of Fus3 activation (B) and total
Fus3-GFP protein levels (C) in wild-type (dotted line) and bni1D (solid line)
cells. Responses are not to scale. Each value is the average from three
experiments (6SE).findings may be relevant to understanding the regulation of
other periodic morphogenetic processes, such as neuronal
development, segmentation, cell locomotion, and contrac-
tility.
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